Oncternal Therapeutics Inc
NASDAQ:ONCT
Equity Financing / Related
Oncternal Therapeutics Increases Previously Announced Bought Deal To $75 Mln
Published: 12/10/2020 05:31 GMT
Oncternal Therapeutics Inc (ONCT) - Oncternal Therapeutics Increases Previously Announced Bought Deal to $75.0 Million.
Oncternal Therapeutics- Increased Size of Offering, Purchase on a Firm Commitment Basis 16.7 Million Shares of Stock at Price of $4.50 per Share.
Oncternal Therapeutics- Intends to Use Proceeds for Expenses Related to Development of Some Therapies.
Oncternal Therapeutics- Increased Size of Offering, Purchase on a Firm Commitment Basis 16.7 Million Shares of Stock at Price of $4.50 per Share.
Oncternal Therapeutics- Intends to Use Proceeds for Expenses Related to Development of Some Therapies.